U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06808750) titled 'Performance of Tests for Schistosoma Haematobium Diagnosis' on Jan. 08.
Brief Summary: Urogenital schistosomiasis caused by infection with the blood fluke Schistosoma haematobium is a debilitating disease. The World Health Organization (WHO) has set the goal to eliminate schistosomiasis as a public health problem globally by 2030 and to interrupt transmission in selected areas. Many years of control interventions and mass drug administration have reduced substantially the prevalence and infection intensities in several areas. In areas with an infection prevalence <10%, the WHO suggests to continue population preventive chemotherapy w...